Novavax Inc. sell JPMorgan Chase & Co.
Start price
12.08.24
/
50%
€10.93
Target price
12.08.25
€8.23
Performance (%)
-34.15%
End price
13.08.25
€7.20
Summary
This prediction ended on 13.08.25 with a price of €7.20. JPMorgan_Chase___Co_ correctly predicted massive losses of -34.15% for Novavax Inc.. JPMorgan_Chase___Co_ has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Sell. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | 1.227% | 1.227% | -30.513% |
| iShares Core DAX® | 0.650% | 3.212% | 21.634% |
| iShares Nasdaq 100 | 1.650% | 0.322% | 5.422% |
| iShares Nikkei 225® | 1.232% | 1.549% | 15.333% |
| iShares S&P 500 | 1.413% | 0.282% | 3.125% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at JPMorgan Chase & Co. from $8.00 to $9.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten